Sherry Bullens,Stuart Bunting,Tianwei Chou,Augustus O. Okhamafe,Christopher P. Price,Daniel J. Wendt,Clarence Yap
申请号：
US15225355
公开号：
US09907834B2
申请日:
2016.08.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
